{"id":"W4408981570","doi":"10.1016/s1556-0864(25)00489-7","title":"297MO: Patterns of disease progression with durvalumab (D) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Results from ADRIATIC","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Oncology; Stage (stratigraphy); Chemoradiotherapy; Internal medicine; Disease; Cancer; Lung cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007163166,0.0002502906,0.001089812,0.0004379287,0.00004009761,0.00001733889,0.0002459812,0.0001339119,0.0001431065],"category_scores_gemma":[0.0002757432,0.0001671433,0.0001657118,0.0003766672,0.0001547902,0.00009368262,0.0001105774,0.0007233716,0.000001018695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001342527,"about_ca_system_score_gemma":0.002233568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00025887,"about_ca_topic_score_gemma":0.0006792613,"domain_scores_codex":[0.9973322,0.0003709535,0.001001412,0.0003296946,0.0005713639,0.000394415],"domain_scores_gemma":[0.9976498,0.0004337097,0.000853467,0.0003471141,0.0004482164,0.0002676632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09212701,0.002455954,0.7887275,0.003100348,0.001124637,0.002582164,0.003022779,0.00014238,0.002750479,0.000005680354,0.00269877,0.1012624],"study_design_scores_gemma":[0.02820669,0.005249263,0.91685,0.01781134,0.001789367,0.00003001225,0.001101488,0.002126522,0.01029539,0.00003195972,0.01609164,0.0004163333],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9722075,0.0168623,0.0002359945,0.008703509,0.0005579609,0.000873915,0.0001869703,0.00001263881,0.0003591466],"genre_scores_gemma":[0.9933252,0.003682167,0.001101143,0.0004412082,0.0003056191,0.0001075386,0.00001493796,0.00002841983,0.0009937459],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1281226,"threshold_uncertainty_score":0.6815906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02263174789021557,"score_gpt":0.4437401101460588,"score_spread":0.4211083622558432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}